Cappella has developed a novel solution for the treatment of ostial and bifurcated disease. Cappella's Sideguard OPD™ (Ostium Protection Device) differs from current approaches for treating bifurcations, because the device conforms to the anatomy of the bifurcated segment. Consequently, the Sideguard OPD™ has demonstrated ease of use and excellent clinical results. Cappella believes its technology is uniquely suited to the complexities associated with coronary bifurcation disease.
Contact : Dr Ascher Shmulewitz,Chairman CEO
ascher@medgp.net
Cappella Inc. Cappella Medical Devices Ltd.
Unit 3, Ballybrit Industrial Park
Ballybrit,
Galway, Ireland
Telephone +353 91 75 8939